Abu Dhabi, UAE — New evidence supports the use of direct oral anticoagulants (DOACs) in the treatment of cerebral venous thrombosis (CVT) based on findings from a new prospective, observational study.

Patients with cerebral venous thrombosis (CVT) had a threefold higher risk for cancer than individuals in the general population, according to a new study. Men older than 50 years had the highest ...

Doctors typically use brain imaging (MRI/CT scans) to identify CVT, however, these tests may not be routinely ordered for patients presenting with headaches or seizures. Recent evidence suggests that ...

Design and structure of the device with photos of the device geometrical changes with controllable length/diameter ratio (left). Magnetic resonance black-blood thrombus imaging showed a significant ...

The UB team that a decade ago helped usher in a new era in acute stroke treatment has turned its innovative approach to addressing the rare but potentially deadly phenomena when multiple blood clots ...

National Institute of Neurological Disorders and Stroke investigators at the National Institutes of Health traced meningeal immune activity to dural venous sinuses that actively constrict and dilate, ...

A practical calculator that predicts the risk of epilepsy after venous stroke is presented in a study from the University of Gothenburg and others. The aim is to improve care for those affected, which ...

Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company and pioneer in venous sinus stenosis treatment, today announced the Company received U.S. Food and Drug Administration (FDA) ...